A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End‐Stage Kidney Disease on Hemodialysis

Documenti analoghi

• Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
  di: Annie Lumen, et al.
  Pubblicazione: (2024)
• Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
  di: Shichang Miao, et al.
  Pubblicazione: (2024)
• A Unified Approach to Calculating Sylvester Sums
  di: Gupta, Neha, et al.
  Pubblicazione: (2025)
• Narrative Evaluation Report On: An HEA Institute for Training in Librarianship for Drug Education For Academic and School Library Media Specialists.
  di: Marbury, Carl H.
  Pubblicazione: (1971)
• Frobenius numbers associated with Diophantine triples of $x^2+y^2=z^r$ (extended version)
  di: Komatsu, Takao, et al.
  Pubblicazione: (2024)